Our dedicated team of regulatory, technical, and project management experts have vast experience in transitioning medicines seamlessly into our manufacturing and distribution networks; working with vendors to ensure there is no disruption in supply to wholesalers, hospitals, pharmacies, and, most importantly, patients.
Ennogen owns and markets a niche portfolio of medicines throughout the UK. Our experienced team work on developing and launching generic medicines for niche indications.
Once we have successfully transitioned an acquired molecule or launched a developed medicine, our In-Line team takes over the life cycle management of the medicines, making sure we maintain the highest standard of ethical medical practice, manage our supply chain effectively and responsibly and deliver high-quality medicines to our patients.








